Crossbow Therapeutics
Expanding the reach of antibody therapeutics.
$77M Series B+ ·
Led by Arkin Bio Ventures · Source: fundraisingfox.com
Total raised: $157M across 2 sourced rounds
All 2 rounds ↓Signals
About Crossbow Therapeutics
Crossbow Therapeutics is determined to revolutionize the reach of cancer treatment by developing potent and precise therapies that can target the entire universe of cancer antigens.
Crossbow Therapeutics | 718 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $77M | fundraisingfox.com | ||
| Series A | $80M | vcaonline.com |
Timeline
- Website created
Founders and team
GP
Geraldine Paulus FounderPB
Patrick Baeuerle FounderTF
Todd Foley Co-founderLinkedIn · source: crossbowtx.comBM
Briggs Morrison President, Chief Executive Officer
Investors
AArkin Bio Ventureslead investor
BBiotechnology Value Fund
BBlood Cancer United, Inc.
EEli Lilly
HHamilton Square Partners Management
MMirae Asset Capital
MMirae Asset Venture Investment
MMPM BioImpact
MMPM Capitallead investor
PPfizer Venture Investmentslead investor
PPolaris
SSixty Degree Capital
TTaiho Ventureslead investor
Companies like Crossbow Therapeutics
OOna Therapeutics$86.6M Series B+ · Oct 2026
TTacalyx$12.88M Seed · Apr 2026
IImmuno Cancer BiotherapeuticsSeed · Oct 2026
CCartography Biosciences$67M Series B+ · Oct 2025
KK2 Therapeutics$50M Seed · Aug 2026
NNormunity$75M Series B+ · Jan 2025
Other companies backed by Arkin Bio Ventures
AAmbros Therapeutics$125M Series A · Dec 2025
AActithera$75.5M Series A · Jul 2025
Arkin Bio Ventures portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/crossbow-therapeutics (get a free API key).